AU2015339203B2 - Delivery systems - Google Patents

Delivery systems Download PDF

Info

Publication number
AU2015339203B2
AU2015339203B2 AU2015339203A AU2015339203A AU2015339203B2 AU 2015339203 B2 AU2015339203 B2 AU 2015339203B2 AU 2015339203 A AU2015339203 A AU 2015339203A AU 2015339203 A AU2015339203 A AU 2015339203A AU 2015339203 B2 AU2015339203 B2 AU 2015339203B2
Authority
AU
Australia
Prior art keywords
yarn
active
article
coating
release
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2015339203A
Other languages
English (en)
Other versions
AU2015339203A1 (en
Inventor
David Anderson
Erik Scott GOEBEL
Jordan Schindler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Textile Based Delivery Inc
Original Assignee
Textile Based Delivery Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Textile Based Delivery Inc filed Critical Textile Based Delivery Inc
Publication of AU2015339203A1 publication Critical patent/AU2015339203A1/en
Application granted granted Critical
Publication of AU2015339203B2 publication Critical patent/AU2015339203B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/203—Retinoic acids ; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0092—Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/24—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/40—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing ingredients of undetermined constitution or reaction products thereof, e.g. plant or animal extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/26—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/402—Anaestetics, analgesics, e.g. lidocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/41—Anti-inflammatory agents, e.g. NSAIDs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/43—Hormones, e.g. dexamethasone

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Materials Engineering (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Inorganic Chemistry (AREA)
  • Nanotechnology (AREA)
  • Neurology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Anesthesiology (AREA)
  • Zoology (AREA)
  • Botany (AREA)
  • Pain & Pain Management (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Polymers & Plastics (AREA)
  • Professional, Industrial, Or Sporting Protective Garments (AREA)
AU2015339203A 2014-10-30 2015-10-29 Delivery systems Ceased AU2015339203B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462072896P 2014-10-30 2014-10-30
US62/072,896 2014-10-30
PCT/US2015/058059 WO2016069898A1 (en) 2014-10-30 2015-10-29 Delivery systems

Publications (2)

Publication Number Publication Date
AU2015339203A1 AU2015339203A1 (en) 2017-04-20
AU2015339203B2 true AU2015339203B2 (en) 2020-12-24

Family

ID=55851473

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2015339203A Ceased AU2015339203B2 (en) 2014-10-30 2015-10-29 Delivery systems

Country Status (10)

Country Link
US (7) US9669012B2 (enExample)
EP (1) EP3212173A4 (enExample)
JP (1) JP6896625B2 (enExample)
KR (1) KR20170076756A (enExample)
CN (1) CN107205956A (enExample)
AU (1) AU2015339203B2 (enExample)
BR (1) BR112017007942A2 (enExample)
CA (1) CA3003397A1 (enExample)
MX (1) MX2017005399A (enExample)
WO (1) WO2016069898A1 (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014160744A1 (en) * 2013-03-26 2014-10-02 Innovia Llc Pacemaker lead and other medical implant devices
US9669012B2 (en) 2014-10-30 2017-06-06 Textile-Based Delivery, Inc. Delivery systems
US11690928B2 (en) * 2017-07-17 2023-07-04 Peter Rigg Fragrance delivery systems
WO2019094546A1 (en) * 2017-11-13 2019-05-16 Casey Nicole Warp yarn of woven textiles
CN112739322B (zh) 2018-09-18 2024-06-21 玫琳凯有限公司 减少色素沉着过度的皮肤外观或提亮皮肤的植物提取物
EP3666939B1 (en) 2018-12-12 2024-10-30 Aladdin Manufacturing Corporation A multifilament bundle of melt spun polymer filaments
CA3162023A1 (en) * 2019-12-31 2021-07-08 Amnon VARDI Extended release plastic formulation
US20210259985A1 (en) * 2020-02-20 2021-08-26 WeDoWee, LLC Method of providing cbd oil within polymer fibrous structures for subsequent transfer to a user's skin
IT202000005515A1 (it) * 2020-03-16 2021-09-16 U Earth Biotech Ltd Maschera filtrante perfezionata
US12071713B2 (en) 2020-06-16 2024-08-27 Aladdin Manufacturing Corporation Systems and methods for producing a bundle of filaments and/or a yarn
CA3181984A1 (en) 2020-06-16 2021-12-23 Anthony CASCIO Systems and methods for producing a bundle of filaments and/or a yarn
EP4165240B1 (en) 2020-06-16 2025-10-01 Aladdin Manufacturing Corporation Systems and methods to provide color enhanced yarns
US12186512B2 (en) * 2020-10-26 2025-01-07 Christopher Green Treatment for dry eyes
US12029718B2 (en) 2021-11-09 2024-07-09 Cct Sciences, Llc Process for production of essentially pure delta-9-tetrahydrocannabinol
AU2022229531A1 (en) 2021-03-05 2023-08-17 H.B. Fuller Company Cyanoacrylate composition with hazardless stabilizer
IT202100006290A1 (it) 2021-03-16 2022-09-16 U Earth Biotech Ltd Una maschera facciale indossabile e configurata per filtrare l’aria inalata da un utente
IT202100006284A1 (it) 2021-03-16 2022-09-16 U Earth Biotech Ltd Mezzi di filtraggio di una maschera facciale indossabile
CN117203383A (zh) * 2021-04-23 2023-12-08 美国阿拉丁制造公司 制造纱线的方法和以该方式获得的纱线
WO2022238862A1 (en) * 2021-05-12 2022-11-17 Aladdin Manufacturing Corporation Fibers with active additives technical field
US20220372695A1 (en) * 2021-05-20 2022-11-24 Textile-Based Delivery, Inc. Active agent indicator for textiles
CN114045587B (zh) * 2021-11-10 2022-09-02 武汉纺织大学 基于亲水改性壳聚糖的复合纱线止血材料
US12245644B2 (en) * 2022-04-28 2025-03-11 Tamika MAYES Support garments
CN114959966B (zh) * 2022-07-15 2023-04-18 苏州赛恩环境科技有限公司 一种内注甲醛清除剂的纤维线生产设备及方法

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3854480A (en) * 1969-04-01 1974-12-17 Alza Corp Drug-delivery system
GB1412970A (en) * 1974-01-15 1975-11-05 Schering Ag Pharmaceutical preparations containing silicone rubber
US3992518A (en) * 1974-10-24 1976-11-16 G. D. Searle & Co. Method for making a microsealed delivery device
US20040162580A1 (en) * 2000-08-17 2004-08-19 Matthew Hain Sutures and coatings made from therapeutic absorbable glass
WO2015184407A1 (en) * 2014-05-30 2015-12-03 Textile-Based Delivery, Inc. Drug delivery systems and related methods of use

Family Cites Families (80)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1814853A (en) 1930-01-13 1931-07-14 Dow Chemical Co Method of purifying methyl salicylate
US2799598A (en) 1951-08-17 1957-07-16 Owens Corning Fiberglass Corp Process of forming coated twisted yarns and woven fabrics and resultant article
US3674901A (en) * 1966-07-26 1972-07-04 Nat Patent Dev Corp Surgical sutures
US3845761A (en) * 1970-06-02 1974-11-05 Alza Corp Intrauterine contraceptive anti-fertility device for the management of reproduction
JPS4840924B1 (enExample) * 1970-09-26 1973-12-04
US3845791A (en) 1970-10-15 1974-11-05 Continental Can Co Universal filling head
BE789524A (fr) * 1971-09-30 1973-01-15 Alza Corp Dispositif de liberation de medicaments
US3948254A (en) 1971-11-08 1976-04-06 Alza Corporation Novel drug delivery device
US3993072A (en) 1974-08-28 1976-11-23 Alza Corporation Microporous drug delivery device
US4314557A (en) 1980-05-19 1982-02-09 Alza Corporation Dissolution controlled active agent dispenser
JPS6072550A (ja) * 1983-09-27 1985-04-24 日東電工株式会社 創傷カバ−剤
US4638043A (en) * 1984-11-13 1987-01-20 Thermedics, Inc. Drug release system
US4751133A (en) * 1984-11-13 1988-06-14 Thermedics, Inc. Medical patches and processes for producing same
US6040251A (en) * 1988-03-14 2000-03-21 Nextec Applications Inc. Garments of barrier webs
US5221722A (en) * 1988-11-28 1993-06-22 The B. F. Goodrich Company Crosslinked polyacrylic acid
EP0395476A3 (en) * 1989-04-28 1992-01-08 Ricoh Kyosan Inc. Method and apparatus for the production of ionic cloths for use in ionic dressings
FR2664815B1 (fr) * 1990-07-23 1994-11-04 Adir Systeme matriciel autoadhesif pour la liberation prolongee du piribedil par voie transcutanee.
JP3571717B2 (ja) 1991-10-04 2004-09-29 ゲー・エス・デイベロツプメント・アクチエボラーグ 粒子、該粒子の製法及びその使用
US5353820A (en) * 1992-02-06 1994-10-11 Gillette Canada Inc. Flavored dental cleaning article and method
US5299335A (en) 1993-08-23 1994-04-05 Ivester Philip K Fragrance-releasing pillow and the like
US6103644A (en) * 1993-12-22 2000-08-15 Nordico Marketing Development, Inc. Impregnated matrix and method for making same
US5660848A (en) 1994-11-02 1997-08-26 The Population Council, Center For Biomedical Research Subdermally implantable device
ATE295157T1 (de) 1996-01-30 2005-05-15 Novagent Oy Mittel zur transdermalen verabreichung von arzneistoffen
US6638621B2 (en) 2000-08-16 2003-10-28 Lyotropic Therapeutics, Inc. Coated particles, methods of making and using
US6020412A (en) * 1997-12-04 2000-02-01 Mitsubishi Polyester Film, Llc Controlled release coating comprising blend of silicone polymer and adhesion promoter
US5932617A (en) * 1998-02-06 1999-08-03 Woundfast Pharmaceuticals Inc. Wound-treating composition and method
JP2000096443A (ja) * 1998-09-25 2000-04-04 Toray Ind Inc 繊維布帛およびその製造方法
US5965137A (en) 1998-11-16 1999-10-12 Advanced Medical Instruments Insect repellent composition and method for inhibiting the transmission and treatment of symptoms of vector-borne diseases
JP2000212873A (ja) * 1999-01-18 2000-08-02 Nonogawa Shoji Kk 機能性繊維
US6596296B1 (en) * 1999-08-06 2003-07-22 Board Of Regents, The University Of Texas System Drug releasing biodegradable fiber implant
US7033603B2 (en) 1999-08-06 2006-04-25 Board Of Regents The University Of Texas Drug releasing biodegradable fiber for delivery of therapeutics
US6158253A (en) * 1999-09-17 2000-12-12 Knit-Rite, Inc. Seamless, form fitting foot sock
JP2001097839A (ja) * 1999-09-28 2001-04-10 Shiseido Co Ltd 加齢臭抑制繊維および繊維処理剤
GB2373477B (en) * 1999-12-27 2004-02-25 Kimberly Clark Co Nonwoven fabrics providing controlled active agent delivery
AU2001268048A1 (en) * 2000-06-02 2001-12-17 Milliken And Company Yarns and fabrics having a wash-durable non-electrically conductive topically applied metal-based finish
GB0024884D0 (en) 2000-10-11 2000-11-22 Astrazeneca Ab Method
US20020102280A1 (en) 2000-11-29 2002-08-01 Anderson David M. Solvent systems for pharmaceutical agents
DE60110192T2 (de) 2000-12-07 2006-03-09 Warner-Lambert Company Llc Verfahren und System zur gleichmäßigen Arzneistoffabgabe
MXPA03009727A (es) 2001-04-26 2004-01-29 Control Delivery Sys Inc SISTEMA DE SUMINISTRO DE FaRMACOS DE LIBERACIoN PROLONGADA QUE CONTIENE COFARMACOS.
FR2826380B1 (fr) 2001-06-22 2007-03-16 Nathalie Chetboun Procede de traitement anti-acariens et anti-microbien des materiaux textiles par huile naturelle microencapsulee
WO2003000236A1 (en) 2001-06-23 2003-01-03 Lyotropic Therapeutics, Inc Particles with improved solubilization capacity
CN1320063C (zh) 2001-10-17 2007-06-06 三仪股份有限公司 抗菌性复合粒子和抗菌性树脂组合物
JP2005511144A (ja) * 2001-12-03 2005-04-28 シー・アール・バード・インク 微生物耐性医療用具、微生物耐性ポリマーコーティング及びその製造方法
GB0130608D0 (en) 2001-12-21 2002-02-06 Psimedica Ltd Medical fibres and fabrics
US8871241B2 (en) 2002-05-07 2014-10-28 Psivida Us, Inc. Injectable sustained release delivery devices
CA2484632C (en) 2002-05-07 2012-12-11 Control Delivery Systems, Inc. Processes for forming a drug delivery device
WO2004043435A2 (en) 2002-11-13 2004-05-27 Control Delivery Systems, Inc. Systemic delivery of antiviral agents
JP2004195348A (ja) * 2002-12-18 2004-07-15 Akatsuki Kinzoku Kogyo:Kk 塗工シート加工装置および貼付剤
WO2004073843A1 (en) 2003-02-19 2004-09-02 Mcmaster University Composite materials comprising supported porous gels
JP4471975B2 (ja) * 2003-06-30 2010-06-02 ザ プロクター アンド ギャンブル カンパニー コーティングされたナノファイバーのウェブ
US7713440B2 (en) 2003-10-08 2010-05-11 Lyotropic Therapeutics, Inc. Stabilized uncoated particles of reversed liquid crystalline phase materials
DE102004037752A1 (de) * 2004-08-04 2006-03-16 Cognis Deutschland Gmbh & Co. Kg Ausgerüstete Fasern und textile Flächengebilde
US8048446B2 (en) 2005-05-10 2011-11-01 Drexel University Electrospun blends of natural and synthetic polymer fibers as tissue engineering scaffolds
US7736695B2 (en) 2005-05-23 2010-06-15 Appleton Papers Inc. Oil-in-water capsule manufacture process and microcapsules produced by such process
CN101232815A (zh) 2005-06-03 2008-07-30 巴斯福股份公司 用于浸渍纤维、织物和网状物而赋予抗害虫保护活性的组合物
CN1883438A (zh) 2005-06-21 2006-12-27 香港理工大学 温度响应性智能面膜及其制备方法
JP5283509B2 (ja) * 2005-12-07 2013-09-04 ラモット・アット・テル・アビブ・ユニバーシテイ・リミテッド 薬物送達複合構造体
US8663674B2 (en) 2006-01-13 2014-03-04 Surmodics, Inc. Microparticle containing matrices for drug delivery
EP2037882B1 (en) 2006-06-28 2014-12-10 SurModics, Inc. Combination degradable and non-degradable matrices for active agent delivery
JP2008057100A (ja) 2006-08-29 2008-03-13 Mmi-Ipco Llc 感温性且つ感湿性のスマートテキスタイル
AU2007292390A1 (en) * 2006-09-08 2008-03-13 Albemarle Corporation Flame retarded textile products and a method of making the same
US8277711B2 (en) 2007-03-29 2012-10-02 E I Du Pont De Nemours And Company Production of nanofibers by melt spinning
WO2009067242A2 (en) 2007-11-20 2009-05-28 Imclone Llc Co-crystal of antibody 11f8 fab fragment and egfr extracellular domain and uses thereof
US20090158492A1 (en) 2007-12-21 2009-06-25 Min Yao Quick-drying textile
BRPI0905679A2 (pt) 2008-01-08 2015-07-07 Quick Med Technologies Inc Método para fabricar e desinfetar um substrato e composição para conferir atividade antimicrobiana durável em um substrato
WO2010065921A2 (en) 2008-12-05 2010-06-10 Lpath, Inc. Antibody design using anti-lipid antibody crystal structures
US20110142898A1 (en) 2009-12-11 2011-06-16 Jerry Fan Devices for treatment of skin disorders
US20110238036A1 (en) 2009-12-23 2011-09-29 Psivida Us, Inc. Sustained release delivery devices
US9901128B2 (en) * 2009-12-24 2018-02-27 David A. Gray Antimicrobial apparel and fabric and coverings
SI2547332T1 (sl) 2010-03-16 2019-01-31 Titan Pharmaceuticals, Inc. Heterogeni vsadljivi pripomočki za dovajanje zdravila
WO2011123723A1 (en) * 2010-03-31 2011-10-06 Enviroscent, Inc. Methods, compositions and articles for olfactory-active substances
CA2795706A1 (en) 2010-04-06 2011-10-13 Allergan, Inc. Sustained-release reservoir implants for intracameral drug delivery
CN102247316B (zh) * 2011-08-16 2013-09-11 上海交通大学 一种控制药物释放的疏水涂层及其制备方法
US20140302249A1 (en) * 2011-08-31 2014-10-09 The University Of Akron Coated fibers exhibiting beads-on-a-string morphology
CN103987378B (zh) * 2011-09-09 2016-12-14 阿克西亚制药有限责任公司 硅氧烷涂覆的植入物
US20150202161A1 (en) * 2012-08-20 2015-07-23 O-Ray Pharma, Inc. Process for manufacturing drug delivery formulations
US20140271863A1 (en) 2013-03-14 2014-09-18 Textile-Based Delivery, Inc. Hot washable poly-n-isopropylacrylamide hydrogel delivery systems
JP2016519222A (ja) * 2013-03-15 2016-06-30 アーセナル メディカル， インコーポレイテッド コア−シース繊維ならびにそれを作製するための方法およびそれを使用するための方法
DE102014208253A1 (de) 2014-04-30 2015-11-05 MAHLE Behr GmbH & Co. KG Abgasanlage für ein Kraftfahrzeug
US9669012B2 (en) 2014-10-30 2017-06-06 Textile-Based Delivery, Inc. Delivery systems

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3854480A (en) * 1969-04-01 1974-12-17 Alza Corp Drug-delivery system
GB1412970A (en) * 1974-01-15 1975-11-05 Schering Ag Pharmaceutical preparations containing silicone rubber
US3992518A (en) * 1974-10-24 1976-11-16 G. D. Searle & Co. Method for making a microsealed delivery device
US20040162580A1 (en) * 2000-08-17 2004-08-19 Matthew Hain Sutures and coatings made from therapeutic absorbable glass
WO2015184407A1 (en) * 2014-05-30 2015-12-03 Textile-Based Delivery, Inc. Drug delivery systems and related methods of use

Also Published As

Publication number Publication date
EP3212173A1 (en) 2017-09-06
KR20170076756A (ko) 2017-07-04
MX2017005399A (es) 2017-07-26
JP2018503598A (ja) 2018-02-08
EP3212173A4 (en) 2018-06-20
WO2016069898A1 (en) 2016-05-06
JP6896625B2 (ja) 2021-06-30
AU2015339203A1 (en) 2017-04-20
US20190105283A1 (en) 2019-04-11
US20170231919A1 (en) 2017-08-17
US20190038568A1 (en) 2019-02-07
US10799464B2 (en) 2020-10-13
US20200390720A1 (en) 2020-12-17
US9669012B2 (en) 2017-06-06
US20160120986A1 (en) 2016-05-05
US20230338301A1 (en) 2023-10-26
US11690808B2 (en) 2023-07-04
BR112017007942A2 (pt) 2017-12-19
CA3003397A1 (en) 2016-05-06
CN107205956A (zh) 2017-09-26
US11633366B2 (en) 2023-04-25
US20230255895A1 (en) 2023-08-17

Similar Documents

Publication Publication Date Title
US20230338301A1 (en) Delivery systems
US20080311163A1 (en) Cosmetic Treatment With Nitric Oxide, Device For Performing Said Treatment And Manufacturing Method Therefor
US20140369949A1 (en) Cosmetic Treatment with Nitric Oxide, Device for Performing Said Treatment and Manufacturing Method Therefor
EP1301180A2 (de) Lösung, dispersion oder emulsion bildende folien-dermatika
EP1658041A1 (de) Körperpflegemittel mit porösen silberpartikeln
JP2006519263A (ja) 皮膚への美容的、皮膚科学的、及び薬学的活性を有する成分の制御されたデリバリーのための目に付かないパッチ
Rezaei et al. Fabrication, characterization, and drug release study of vitamin C–loaded alginate/polyethylene oxide nanofibers for the treatment of a skin disorder
CN106400308A (zh) 一种自芳香天然抗菌除臭非织造布及其应用
CN109010255A (zh) 阿片样物质制剂
US20220401376A1 (en) Delivery systems for release of active compounds
CN107638423A (zh) 一种盐酸特比萘芬长效喷膜剂的经皮递送体系
US20230404935A1 (en) Delivery systems
EP0948363A1 (de) Extrem flexibles, dermal oder transdermal wirkendes pflaster und verfahren zu seiner herstellung
US20220175691A1 (en) Delivery systems for release of active compounds
DE102004038285A1 (de) Aromatherapie
US20150132351A1 (en) Use of a composition containing a polymer and mineral fillers to combat skin aging
WO2014089649A1 (pt) "nanofibras contendo substancia ativa com liberação controlada para aplicação odontológica e processo"
KR101696275B1 (ko) 색조화장이 가능한 나노케어 스팟패치 및 그 제조방법
US20210363673A1 (en) Removable patch with active agent for textiles
CN113440425A (zh) 片型面膜凝胶组合物、包含其的面膜片及面膜片制备方法
ES2808936T3 (es) Una composición antitranspirante con protección frente al olor de larga duración
DE202008001877U1 (de) In engem Hautkontakt zu tragende textile Hemden, Pullover, T-Shirts oder Hosen, beinhaltend Wirkstoffschichten mit einer sich allmählich freisetzenden Wirkstoffdeponie
Shaikh et al. Fabrication of biodegradable nano medical patches incorporating a sustained-release pharmacological agent using electro-spinning technique
JP2004149430A (ja) 衛生用繊維製品およびそれを用いた衛生用品
HK40053442A (en) Sheet type facial mask gel composition, facial mask sheet comprising the same, and manufacturing method of facial mask sheet

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired